Strain identifier

BacDive ID: 4968

Type strain: No

Species: Klebsiella pneumoniae

Strain history: CIP <- 1953, ATCC <- W.A. Randall, FDA, Washington, USA: strain PCI 602

NCBI tax ID(s): 573 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 357

BacDive-ID: 4968

DSM-Number: 681

keywords: genome sequence, 16S sequence, Bacteria, aerobe, mesophilic, Gram-negative, rod-shaped

description: Klebsiella pneumoniae DSM 681 is an aerobe, mesophilic, Gram-negative bacterium of the family Enterobacteriaceae.

NCBI tax id

  • NCBI tax id: 573
  • Matching level: species

strain history

@refhistory
357<- NCTC; NCTC 7427 (Klebsiella aerogenes) <- ATCC; ATCC 10031 <- U.S. Food and Drug Administration (FDA), Washington, D.C., USA; PCI 602
121888CIP <- 1953, ATCC <- W.A. Randall, FDA, Washington, USA: strain PCI 602

doi: 10.13145/bacdive4968.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/pseudomonadota
  • domain: Bacteria
  • phylum: Pseudomonadota
  • class: Gammaproteobacteria
  • order: Enterobacterales
  • family: Enterobacteriaceae
  • genus: Klebsiella
  • species: Klebsiella pneumoniae
  • full scientific name: Klebsiella pneumoniae (Schroeter 1886) Trevisan 1887 (Approved Lists 1980)

  • synonyms

    • @ref: 20215
    • synonym: Hyalococcus pneumoniae

@ref: 357

domain: Bacteria

phylum: Proteobacteria

class: Gammaproteobacteria

order: Enterobacteriales, not validated

family: Enterobacteriaceae

genus: Klebsiella

species: Klebsiella pneumoniae

full scientific name: Klebsiella pneumoniae (Schroeter 1886) Trevisan 1887

type strain: no

Morphology

cell morphology

  • @ref: 121888
  • gram stain: negative
  • cell shape: rod-shaped
  • motility: no

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
357COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://mediadive.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
357TRYPTICASE SOY BROTH AGAR (DSMZ Medium 535)yeshttps://mediadive.dsmz.de/medium/535Name: TRYPTICASE SOY BROTH AGAR (DSMZ Medium 535) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Distilled water
37328MEDIUM 3 - Columbia agaryesColumbia agar (39.000 g);distilled water (1000.000 ml)
121888CIP Medium 72yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72
121888CIP Medium 3yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=3

culture temp

@refgrowthtypetemperaturerange
357positivegrowth37mesophilic
37328positivegrowth30mesophilic
45338positivegrowth37mesophilic
121888positivegrowth30-41
121888nogrowth5psychrophilic
121888nogrowth10psychrophilic

Physiology and metabolism

oxygen tolerance

@refoxygen tolerance
45338aerobe
121888facultative anaerobe

antibiogram

@refmediumincubation temperatureincubation timeoxygen conditionPenicillin Goxacillinampicillinticarcillinmezlocillincefalotincefazolincefotaximeaztreonamimipenemtetracyclinechloramphenicolgentamycinamikacinvancomycinerythromycinlincomycinofloxacinnorfloxacincolistinpipemidic acidnitrofurantoinbacitracinpolymyxin bkanamycinneomycindoxycyclineceftriaxoneclindamycinfosfomycinmoxifloxacinlinezolidnystatinquinupristin/dalfopristinteicoplaninpiperacillin/tazobactam
357Mueller-Hinton Agar371aerob1012141424-263228-304240-423028-303622248208-10383614262401424-262028-3038-4020-2224-2636-3820010030
357Mueller-Hinton Agar37aerob61210-12142430284238303034222602083434142622016262028342026342008-10030
357Mueller-Hinton Agar37aerob61210-12142430284238303034222602083434142622016262028342026342008-10030

compound production

@refcompound
357D ribulokinase
20216D-Ribulokinase
20216quality control

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
6836830849L-arabinose+fermentation
6836827613amygdalin+fermentation
6836828053melibiose+fermentation
6836817992sucrose+fermentation
6836862345L-rhamnose+fermentation
6836830911sorbitol+fermentation
6836817268myo-inositol+fermentation
6836816899D-mannitol+fermentation
6836817634D-glucose+fermentation
683685291gelatin-hydrolysis
6836827897tryptophan-energy source
6836818257ornithine-degradation
6836829016arginine-hydrolysis
12188829864mannitol+fermentation
12188816947citrate+carbon source
12188817234glucose+fermentation
12188817716lactose+fermentation
12188817632nitrate+reduction
12188816301nitrite+reduction
121888132112sodium thiosulfate-builds gas from
12188817234glucose+degradation
6837418257ornithine-degradation
6837429016arginine-hydrolysis
6837425094lysine+degradation
6837416199urea+hydrolysis
6837418403L-arabitol-builds acid from
6837418024D-galacturonic acid+builds acid from
68374Potassium 5-ketogluconate-builds acid from
6837416899D-mannitol+builds acid from
6837417306maltose+builds acid from
6837415963ribitol+builds acid from
6837418394palatinose+builds acid from
6837415792malonate-assimilation
6837427897tryptophan-energy source
6837417634D-glucose+builds acid from
6837417992sucrose+builds acid from
6837430849L-arabinose+builds acid from
6837418333D-arabitol+builds acid from
6837427082trehalose+builds acid from
6837462345L-rhamnose+builds acid from
6837417268myo-inositol+builds acid from
6837417057cellobiose+builds acid from
6837430911sorbitol+builds acid from

antibiotic resistance

  • @ref: 121888
  • metabolite: 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
  • is antibiotic: yes
  • is sensitive: yes
  • is resistant: no

metabolite production

@refChebi-IDmetaboliteproduction
6837435581indoleno
6836835581indoleno
6836816136hydrogen sulfideno
12188835581indoleno

metabolite tests

@refChebi-IDmetaboliteindole testvoges-proskauer-testmethylred-test
6837435581indole-
6836835581indole-
12188815688acetoin+
12188817234glucose-

enzymes

@refvalueactivityec
68382alpha-fucosidase-3.2.1.51
68382alpha-mannosidase-3.2.1.24
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382beta-glucosidase+3.2.1.21
68382alpha-glucosidase+3.2.1.20
68382beta-glucuronidase-3.2.1.31
68382beta-galactosidase+3.2.1.23
68382alpha-galactosidase+3.2.1.22
68382naphthol-AS-BI-phosphohydrolase+
68382acid phosphatase+3.1.3.2
68382alpha-chymotrypsin-3.4.21.1
68382trypsin-3.4.21.4
68382cystine arylamidase-3.4.11.3
68382valine arylamidase-
68382leucine arylamidase+3.4.11.1
68382lipase (C 14)-
68382esterase lipase (C 8)+
68382esterase (C 4)+
68382alkaline phosphatase+3.1.3.1
68374L-aspartate arylamidase-3.4.11.21
68374alpha-maltosidase-
68374alpha-galactosidase+3.2.1.22
68374alpha-glucosidase-3.2.1.20
68374beta-galactosidase+3.2.1.23
68374N-acetyl-beta-glucosaminidase-3.2.1.52
68374beta-glucuronidase-3.2.1.31
68374beta-glucosidase+3.2.1.21
68374lipase-
68374urease+3.5.1.5
68374lysine decarboxylase+4.1.1.18
68374arginine dihydrolase-3.5.3.6
68374ornithine decarboxylase-4.1.1.17
68368cytochrome oxidase-1.9.3.1
68368gelatinase-
68368tryptophan deaminase-4.1.99.1
68368ornithine decarboxylase-4.1.1.17
68368arginine dihydrolase-3.5.3.6
68368beta-galactosidase+3.2.1.23
121888oxidase-
121888beta-galactosidase+3.2.1.23
121888alcohol dehydrogenase-1.1.1.1
121888gelatinase-
121888catalase+1.11.1.6
121888lysine decarboxylase+4.1.1.18
121888ornithine decarboxylase-4.1.1.17
121888tryptophan deaminase-
121888urease+3.5.1.5

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
121888-+++-+----++++-++---

API 20E

@refONPGADH ArgLDC LysODCCITH2SURETDA TrpINDVPGELGLUMANINOSorRHASACMELAMYARAOX
357+---+------+++++++++-
357+-+-+-+----+++++++++-
45338+-+---+--+-+++++++++-
357+-+-+------+++++++++-

API ID32E

@refODCADH ArgLDC LysURELARLGAT5KGLIPRPbeta GLUMANMALADOPLEbeta GURMNTINDbeta NAGbeta GALGLUSACLARADARLalpha GLUalpha GALTRERHAINOCELSORalphaMALAspA
45338--++-+---+++++----+++++-++++++--

API biotype100

@refGLUFRUGALTREMNESBEMELSACRAFMTEMALLACLTEMbGaMaGaCELGENMbGuESCRIBARAXYLPLERHAFUCMLZDARLLARLXLTDULTAGGLYINOMANMTLTURSORADOHBGLYXERYMDG3MDGSATMUCLTATDTATMTATDMLTLMLTCATETATETTECITGRTGAT2KG5KGTRYNAGGNTPACPATpOBEQATGTEmOBEBATPPATCMTTGEBETPCEABTHINLATCAPCYTHISSUCFUMGREGYTAVTETNTTNGLNITA3OBUAPTGTTPRODALALALASERMNTPROPTYR2KT
121888+++++++++++++++++++++++++-+----++++------+-+++--++++-++++--++++++--+-+---+-+---++-+++-+-+++++++----

Safety information

risk assessment

@refbiosafety levelbiosafety level comment
3572Risk group (German classification)
1218882Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Klebsiella pneumoniae strain ATCC 10031 clone 3 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Ile and tRNA-Ala genes, complete sequenceDQ399562427ena573
20218Klebsiella pneumoniae strain ATCC 10031 clone 2 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Ile and tRNA-Ala genes, complete sequenceDQ399563427ena573
20218Klebsiella pneumoniae strain ATCC 10031 clone 1 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceDQ399564343ena573
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L2 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceEU623376343ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L3 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceEU623377343ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L4 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceEU623378343ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L5 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceEU623379343ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L6 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceEU623380343ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L8 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceEU623381343ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L9 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Glu gene, complete sequenceEU623382343ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone S3 16S-23S ribosomal RNA intergenic spacer, partial sequenceEU623383198ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone S5 16S-23S ribosomal RNA intergenic spacer, partial sequenceEU623384198ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone S6 16S-23S ribosomal RNA intergenic spacer, partial sequenceEU623385198ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L1 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Ile and tRNA-Ala genes, complete sequenceEU623386427ena72407
20218Klebsiella pneumoniae subsp. pneumoniae culture-collection ATCC:10031 clone L7 16S-23S ribosomal RNA intergenic spacer, partial sequence; and tRNA-Ile and tRNA-Ala genes, complete sequenceEU623387435ena72407
20218Klebsiella pneumoniae strain ATCC 10031 16S ribosomal RNA gene, partial sequenceFJ971886795ena573

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Klebsiella pneumoniae NCTC7427GCA_900451675contigncbi573
66792Klebsiella pneumoniae strain NCTC7427573.20129wgspatric573

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
gram-positiveno97.431no
anaerobicno96.615yes
halophileno89.201no
spore-formingno94.039no
glucose-utilyes94.609no
thermophileno99.654yes
flagellatedno93.661no
aerobicyes88.971no
motileno83.261no
glucose-fermentyes91.456yes

External links

@ref: 357

culture collection no.: DSM 681, ATCC 10031, NCIB 9111, NCTC 7427, CCUG 10785, NCDC 401-68, PCI 602, CIP 53.153, NCIMB 9111

straininfo link

  • @ref: 74464
  • straininfo: 10831

literature

topicPubmed-IDtitleauthorsjournalyearmeshtopic2DOI
Pathogenicity2810757[Clinical studies on cefteram pivoxil granules in pediatrics].Sato H, Narita A, Nakazawa S, Suzuki H, Matsumoto K, Nakanishi Y, Niino K, Nakazawa SJpn J Antibiot1989Bacterial Infections/*drug therapy, Cefmenoxime/adverse effects/*analogs & derivatives/pharmacokinetics/therapeutic use, Child, Child, Preschool, Drug Evaluation, Humans, InfantEnzymology
Pathogenicity3331159[Determination of the bactericidal potency of cefatrizine and other oral antibiotics against Haemophilus influenzae, Klebsiella pneumoniae and Streptococcus pyogenes].Carlone NA, Cuffini AM, Tullio V, Barone RG Batteriol Virol Immunol1986Administration, Oral, Amoxicillin/pharmacology, Cefaclor/pharmacology, Cefatrizine/*pharmacology, Cephalosporins/*pharmacology, Haemophilus influenzae/*drug effects, Klebsiella pneumoniae/*drug effects, Leucomycins/pharmacology, *Microbial Sensitivity Tests, Miocamycin, Streptococcus pyogenes/*drug effects
Pathogenicity6224682Bioassay procedures for norfloxacin.Bland J, Edison A, Huber JEur J Clin Microbiol1983Anti-Bacterial Agents/*analysis, Biological Assay, Humans, Klebsiella pneumoniae/drug effects, Nalidixic Acid/*analogs & derivatives/analysis/blood/toxicity, Norfloxacin10.1007/BF02029527
8106837Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor.Engel LS, Callegan MC, Hill JM, O'Callaghan RJJ Ocul Pharmacol1993Animals, Aqueous Humor/*chemistry, Biological Assay/*methods, Ciprofloxacin/*analysis, Klebsiella pneumoniae, Microbial Sensitivity Tests, Rabbits, Reproducibility of Results, Sensitivity and Specificity, Staphylococcus aureus, Tobramycin/*analysis10.1089/jop.1993.9.311
Pathogenicity10208763Antibacterial activity of gentamicin and ciprofloxacin against Gram-negative bacteria: interactions with pig and calf sera.Miglioli PA, Silini R, Carzeri O, Grabocka E, Allerberger FPharmacol Res1999Animals, Anti-Infective Agents/*pharmacology, Blood Bactericidal Activity/*drug effects, Cattle, Ciprofloxacin/*pharmacology, Enterobacteriaceae/*drug effects, Escherichia coli/drug effects, Gentamicins/*pharmacology, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Proteus/drug effects, Swine10.1006/phrs.1998.0447
Pathogenicity14522099Clinically significant borderline resistance of sequential clinical isolates of Klebsiella pneumoniae.Wagenlehner FM, Heisig P, Irtenkauf C, Notka F, Decker J, Lehn N, Linde HInt J Antimicrob Agents2003Blotting, Northern, Ciprofloxacin/*pharmacology, Drug Resistance, Bacterial, Humans, Klebsiella pneumoniae/*drug effects/genetics, Microbial Sensitivity Tests10.1016/s0924-8579(03)00126-2
Enzymology15189301Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.Albarellos GA, Kreil VE, Landoni MFJ Vet Pharmacol Ther2004Administration, Oral, Animals, Anti-Infective Agents/administration & dosage/*pharmacokinetics/pharmacology, Area Under Curve, Cats/*metabolism, Chemistry, Pharmaceutical, Ciprofloxacin/administration & dosage/*pharmacokinetics/pharmacology, Female, Injections, Intravenous/veterinary, Klebsiella pneumoniae/*drug effects, Male, Microbial Sensitivity Tests, Veterinary Drugs/administration & dosage/pharmacokinetics/pharmacologyMetabolism10.1111/j.1365-2885.2004.00573.x
Enzymology16050816Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.Albarellos GA, Ambros LA, Landoni MFJ Vet Pharmacol Ther2005Administration, Oral, Animals, Anti-Bacterial Agents/administration & dosage/blood/*pharmacokinetics/pharmacology, Area Under Curve, Cats/*metabolism, Drug Administration Schedule, Female, Injections, Intravenous/veterinary, Klebsiella pneumoniae/drug effects, *Levofloxacin, Male, Microbial Sensitivity Tests, Ofloxacin/administration & dosage/blood/*pharmacokinetics/pharmacologyMetabolism10.1111/j.1365-2885.2005.00669.x
Enzymology16129342Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats.Albarellos GA, Montoya L, Landoni MFVet J2005Administration, Oral, Animals, Anti-Bacterial Agents/*administration & dosage/blood/*pharmacokinetics, Biological Availability, *Cats, Fluoroquinolones/*administration & dosage/blood/*pharmacokinetics, Injections, Intravenous, Quinolones/*administration & dosage/blood/*pharmacokinetics, Statistics as Topic10.1016/j.tvjl.2004.05.011
Pathogenicity18379044Properties and expression of a multidrug efflux pump AcrAB-KocC from Klebsiella pneumoniae.Li DW, Onishi M, Kishino T, Matsuo T, Ogawa W, Kuroda T, Tsuchiya TBiol Pharm Bull2008Carrier Proteins/*chemistry/*genetics, Chromosomes, Bacterial/genetics, Cloning, Molecular, DNA, Bacterial/genetics, Drug Resistance, Multiple, Bacterial/*genetics, Escherichia coli/genetics, Ethidium/metabolism, Fluorescent Dyes, Genes, Bacterial/genetics, Klebsiella pneumoniae/*chemistry/drug effects/*genetics, Microbial Sensitivity Tests, Plasmids/genetics, RNA, Bacterial/genetics, Reverse Transcriptase Polymerase Chain ReactionEnzymology10.1248/bpb.31.577
Phylogeny20645834Evaluation of the antibacterial activity of the methylene chloride extract of Miconia ligustroides, isolated triterpene acids, and ursolic acid derivatives.Cunha WR, de Matos GX, Souza MG, Tozatti MG, Andrade e Silva ML, Martins CH, da Silva R, Da Silva Filho AAPharm Biol2010Anti-Bacterial Agents/analysis/chemistry/isolation & purification/*pharmacology, Brazil, Drug Discovery, Gram-Negative Bacteria/*drug effects, Gram-Positive Bacteria/*drug effects, Magnetic Resonance Spectroscopy, Medicine, Traditional, Melastomataceae/*chemistry, Methylene Chloride/chemistry, Microbial Sensitivity Tests, Molecular Structure, Oleanolic Acid/analogs & derivatives/analysis/chemistry/*pharmacology, Phytotherapy, Plant Components, Aerial/chemistry, Plant Extracts/chemistry/*pharmacology, Spectrometry, Mass, Electrospray Ionization, Triterpenes/analysis/chemistry/isolation & purification/*pharmacologyEnzymology10.3109/13880200903062648
Pathogenicity21723409Preliminary investigation of a mice model of Klebsiella pneumoniae subsp. ozaenae induced pneumonia.Renois F, Jacques J, Guillard T, Moret H, Pluot M, Andreoletti L, de Champs CMicrobes Infect2011Animals, Bronchoalveolar Lavage Fluid/cytology, Colony Count, Microbial, Cytokines/*analysis/metabolism, Disease Models, Animal, Female, Humans, Immunity, Innate, Klebsiella Infections/immunology/microbiology/mortality/*pathology, Klebsiella pneumoniae/classification/immunology/*pathogenicity, Lung/immunology/microbiology/pathology, Macrophages, Alveolar/immunology/microbiology, Mice, Mice, Inbred BALB C, Pneumonia, Bacterial/immunology/microbiology/mortality/*pathology, Spleen/immunology/microbiology/pathology, Time FactorsMetabolism10.1016/j.micinf.2011.05.013
Metabolism22391093Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae.Ogawa W, Onishi M, Ni R, Tsuchiya T, Kuroda TGene2012Bacterial Outer Membrane Proteins/genetics/metabolism, Bacterial Proteins/*genetics/*metabolism, Cloning, Molecular, Drug Resistance, Multiple, Bacterial/*genetics, Erythromycin/pharmacology, Escherichia coli/drug effects/genetics, Escherichia coli Proteins/genetics/metabolism, Ethidium/pharmacology, Gene Expression Regulation, Bacterial, Klebsiella pneumoniae/*drug effects/*genetics/metabolism, Lipoproteins/metabolism, Membrane Transport Proteins/genetics/metabolism, Microbial Sensitivity Tests, Mutation, Novobiocin/pharmacology, Periplasmic Proteins/genetics/metabolism, Rhodamines/pharmacology, Substrate SpecificityPathogenicity10.1016/j.gene.2012.02.008
Pathogenicity22913459Chemical composition and antimicrobial activity of the essential oil of Linum pubescens growing wild in Jordan.Al-Qudah MANat Prod Res2012Anti-Infective Agents/chemistry/*pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Flax/*chemistry, Gas Chromatography-Mass Spectrometry, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Hemiterpenes, Hexanols/analysis, Jordan, Klebsiella pneumoniae/drug effects, Lauric Acids/analysis, Microbial Sensitivity Tests, Oils, Volatile/analysis/*chemistry/*pharmacology, Pentanoic Acids/analysis, Sesquiterpenes, Germacrane/analysis, Staphylococcus aureus/drug effects10.1080/14786419.2012.715291
23131638Silver-embedded modified hyperbranched epoxy/clay nanocomposites as antibacterial materials.Roy B, Bharali P, Konwar BK, Karak NBioresour Technol2012Aluminum Silicates/*chemistry, Anti-Bacterial Agents/*chemical synthesis/chemistry, Clay, Epoxy Compounds/*chemistry, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Nanocomposites/*chemistry/microbiology/ultrastructure, Silver/*chemistry, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared, X-Ray Diffraction10.1016/j.biortech.2012.09.129
Metabolism23844109Virulence of Klebsiella pneumoniae isolates harboring bla KPC-2 carbapenemase gene in a Caenorhabditis elegans model.Lavigne JP, Cuzon G, Combescure C, Bourg G, Sotto A, Nordmann PPLoS One2013Animals, Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics/*metabolism, Caenorhabditis elegans/*growth & development/microbiology, Host-Pathogen Interactions, Klebsiella pneumoniae/*enzymology/pathogenicity/physiology, Microbial Sensitivity Tests, Microbial Viability/drug effects, Plasmids/genetics/metabolism, Species Specificity, Time Factors, Virulence/genetics, beta-Lactamases/genetics/*metabolismPathogenicity10.1371/journal.pone.0067847
Pathogenicity24498649Suppression of stop codon UGA in acrB can contribute to antibiotic resistance in Klebsiella pneumoniae ATCC10031.Onishi M, Mizusawa M, Tsuchiya T, Kuroda T, Ogawa WGene2014Anti-Bacterial Agents/pharmacology, Bacterial Proteins/*genetics, Codon, Nonsense/genetics, *Codon, Terminator, Drug Resistance, Microbial, Genes, MDR/*genetics, Klebsiella Infections/drug therapy/genetics, Klebsiella pneumoniae/*drug effects/*genetics, Multidrug Resistance-Associated Proteins/*genetics, Sequence Analysis, DNATranscriptomeS0378-1119(13)01424-8
Pathogenicity25481459Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.Agudelo M, Rodriguez CA, Zuluaga AF, Vesga OInt J Antimicrob Agents2014Animals, Anti-Bacterial Agents/pharmacokinetics/*pharmacology/therapeutic use, Bacterial Infections/*drug therapy, *Disease Models, Animal, Enterobacter cloacae/drug effects, Humans, Mesothelin, Mice, Microbial Sensitivity Tests, Penicillanic Acid/*analogs & derivatives/pharmacokinetics/pharmacology/therapeutic use, Piperacillin/pharmacokinetics/*pharmacology/therapeutic use, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, TazobactamEnzymology10.1016/j.ijantimicag.2014.10.014
Pathogenicity25807080Characterization of MATE-type multidrug efflux pumps from Klebsiella pneumoniae MGH78578.Ogawa W, Minato Y, Dodan H, Onishi M, Tsuchiya T, Kuroda TPLoS One2015Amino Acid Sequence, Anti-Bacterial Agents/pharmacology, Bacterial Proteins/*genetics, Cloning, Molecular/methods, Drug Resistance, Multiple, Bacterial/*genetics, Escherichia coli/drug effects/genetics, Klebsiella pneumoniae/*genetics, Membrane Transport Proteins/*genetics, Microbial Sensitivity Tests/methods, Molecular Sequence Data, Plasmids/genetics, Proton-Motive Force/genetics, RNA, Messenger/genetics, Sequence AlignmentEnzymology10.1371/journal.pone.0121619
Pathogenicity26311842Gradual increase in antibiotic concentration affects persistence of Klebsiella pneumoniae.Ren H, He X, Zou X, Wang G, Li S, Wu YJ Antimicrob Chemother2015Anti-Bacterial Agents/*pharmacology, *Drug Tolerance, Humans, Klebsiella pneumoniae/*drug effects/*physiology, Microbial Viability/*drug effects10.1093/jac/dkv251
Pathogenicity27616887An integrated study on antimicrobial activity and ecotoxicity of quantum dots and quantum dots coated with the antimicrobial peptide indolicidin.Galdiero E, Siciliano A, Maselli V, Gesuele R, Guida M, Fulgione D, Galdiero S, Lombardi L, Falanga AInt J Nanomedicine2016Anti-Bacterial Agents/*chemistry, Anti-Infective Agents/*chemistry, Antimicrobial Cationic Peptides/*chemistry, Antioxidants/chemistry, Comet Assay, Escherichia coli/drug effects, Gram-Negative Bacteria/*drug effects, Humans, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Mutation, Oxidative Stress, Pseudomonas aeruginosa/drug effects, Quantum Dots/*chemistry, Reactive Oxygen Species/chemistry, Salmonella typhimurium/drug effects, Staphylococcus aureus/drug effects, Vibrio/drug effects10.2147/IJN.S107752
Pathogenicity29309652Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa.Holfeld L, Knappe D, Hoffmann RJ Antimicrob Chemother2018Anti-Infective Agents/*pharmacology, Antimicrobial Cationic Peptides/*pharmacology, Escherichia coli/*drug effects, Klebsiella pneumoniae/*drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/*drug effects10.1093/jac/dkx482
Pathogenicity30392156N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.Asadipour A, Moshafi MH, Khosravani L, Moghimi S, Amou E, Firoozpour L, Ilbeigi G, Beiki K, Soleimani E, Foroumadi ADaru2018Anti-Bacterial Agents/*chemical synthesis/chemistry/pharmacology, Bacillus subtilis/drug effects, Ciprofloxacin/*analogs & derivatives/chemistry, Drug Design, Fluoroquinolones/*chemical synthesis/chemistry/pharmacology, Gram-Positive Bacteria/*drug effects, Microbial Sensitivity Tests, Molecular Structure, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Structure-Activity Relationship10.1007/s40199-018-0226-0
32120894Allium ursinum and Allium oschaninii against Klebsiella pneumoniae and Candida albicans Mono- and Polymicrobic Biofilms in In Vitro Static and Dynamic Models.Galdiero E, Di Onofrio V, Maione A, Gambino E, Gesuele R, Menale B, Ciaravolo M, Carraturo F, Guida MMicroorganisms202010.3390/microorganisms8030336
Phylogeny32451685Potential of a Bacteriophage Isolated from Wastewater in Treatment of Lobar Pneumonia Infection Induced by Klebsiella pneumoniae in Mice.Soleimani Sasani M, Eftekhar FCurr Microbiol2020Animals, *Bacteriophages, Iran, *Klebsiella Infections/therapy, Klebsiella pneumoniae, Mice, Mice, Inbred BALB C, *Pneumonia, Waste Water10.1007/s00284-020-02041-z
Enzymology35162856Capillary Zone Electrophoresis in Tandem with Flow Cytometry in Viability Study of Various ATCC Bacterial Strains under Antibiotic Treatment.Kupczyk W, Maslak E, Railean-Plugaru V, Pomastowski P, Jackowski M, Buszewski BInt J Environ Res Public Health2022*Anti-Bacterial Agents/pharmacology, *Bacteria, Electrophoresis, Capillary, Flow Cytometry, Microbial Sensitivity Tests10.3390/ijerph19031833
Metabolism35296704The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection.Bleriot I, Blasco L, Pacios O, Fernandez-Garcia L, Ambroa A, Lopez M, Ortiz-Cartagena C, Cuenca FF, Oteo-Iglesias J, Pascual A, Martinez-Martinez L, Domingo-Calap P, Wood TK, Tomas MSci Rep2022Bacterial Proteins/genetics/metabolism, *Bacteriophages/genetics/metabolism, Klebsiella pneumoniae/metabolism, Plasmids/genetics, *Toxin-Antitoxin Systems10.1038/s41598-022-08111-5
Pathogenicity35776759Azithromycin possesses biofilm-inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia.Moshynets OV, Baranovskyi TP, Cameron S, Iungin OS, Pokholenko I, Jerdan R, Kamyshnyi A, Krikunov AA, Potochilova VV, Rudnieva KL, Spiers AJPLoS One2022Anti-Bacterial Agents/pharmacology/therapeutic use, Azithromycin/pharmacology/therapeutic use, Biofilms, Colistin/pharmacology/therapeutic use, Humans, *Klebsiella Infections/microbiology, Klebsiella pneumoniae, Mesylates, Microbial Sensitivity Tests, *Pneumonia/drug therapy, Polymyxin B/pharmacology/therapeutic use10.1371/journal.pone.0270983
35914048Immunogenic Evaluation of MPEG-PCL & PLGA Nanoparticles Containing Klebsiella pneumoniae K2O1 Capsular Antigen in Pulmonary Infection Model of Mice.Ghaderinia P, Shapouri R, Rostamizadeh K, Khodavandi A, Mahdavi MIEEE Trans Nanobioscience202210.1109/TNB.2022.3195483
36375680Semisynthesis, in silico study and in vitro antibacterial evaluation of fucosterol derivatives.da Silva FEF, Avila FDN, Pereira NMO, de Freitas MD, Pessoa ODL, da Fonseca AM, da Costa JGM, Santiago GMPSteroids202210.1016/j.steroids.2022.109137

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
357Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 681)https://www.dsmz.de/collection/catalogue/details/culture/DSM-681
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20216Curators of the HKIhttp://www.leibniz-hki.de/de/Collection Description Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut (HKI)
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
37328Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/16966
45338Curators of the CCUGCulture Collection University of Gothenburg (CCUG) (CCUG 10785)https://www.ccug.se/strain?id=10785
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
68368Automatically annotated from API 20E
68374Automatically annotated from API ID32E
68382Automatically annotated from API zym
74464Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID10831.1StrainInfo: A central database for resolving microbial strain identifiers
121888Curators of the CIPCollection of Institut Pasteur (CIP 53.153)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2053.153